VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.370
-0.004 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.366
-0.004 (-1.19%)
After-hours: Dec 5, 2025, 7:38 PM EST
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $12.32 million as of December 5, 2025. Its market cap has decreased by -69.31% in one year.
Market Cap
12.32M
Enterprise Value
-20.38M
1-Year Change
-69.31%
Ranking
Category
Stock Price
$0.37
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $12.32M, a decrease of -94.64%. That is a compound annual growth rate of -39.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 12.46M | -74.79% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |